叶俊梅,女,2004年获得武汉大学临床医学本科学位,2011年获得武汉大学内科学博士学位,2013获得西班牙莱里达大学分子生物学博士学位。
现为生物化学系副教授,主讲课程包括《医学生物化学》、《Introduction to Biochemistry》、《生物化学与分子生物学实验》、《Advanced Biochemistry》。
主要从事心肌梗死、充血性心力衰竭、高血压性心肌病及糖尿病性心肌损伤的分子机制研究,并针对这些疾病的发病机制和主要靶标,开展治疗药物的设计、优化及验证;同时也针对这些疾病的重要分子靶点开展基因治疗及效果评价。
近年来主持国家自然科学青年基金、江苏省青年基金及江苏省面上基金。
糖尿病性心肌及肝脏损伤分子机制;心肌梗死后心肌细胞修复及再生;心力衰竭的分子机制及治疗靶标。 |
1. 江苏省面上基金,(编号:BK20191324):2019年7月—2022年6月,SIRT6通过AKT2/AMPK信号通路调控糖尿病性心肌病变的机制研究。10万,已结题,主持。
2. 国家自然科学青年基金,(编号:81500179):2016年1月—2018年12月,心脏Endo G缺失导致心肌肥大的机制研究。18万,已结题,主持。
3. 江苏省青年基金,(编号:BK201510696):2015年7月—2018年6月,心肌细胞Endo G缺失导致心肌肥大的分子机制研究。20万,已结题,主持。
4. 江苏省留学回国人员资助项目:2015年1月-2019年12月,心肌细胞EndoG缺失导致心肌肥厚的机制。2万,已结题,主持。
1) Weixian Kong#, Jiawen Chen#, Xinjia Ruan#, Xie Li, Xiaozhi Xu, Mengmeng Bao, Yuru Shao, Xiaohong Bian, Ruiyan Li, Qizhou Jiang, Yubin Zhang, Zhe Li*, Fangrong Yan*, Junmei Ye*. Cardiac Injury Activates STING Signaling via Upregulating SIRT6 in Macrophages After Myocardial Infarction. Life Sciences. (IF=6.1)(2024)
2) Kong W#, Peng Y#, Ji C#, Liu Z, Gao S, Zhang Y, Chen J, Li X, Bao M, Zhang Y, Jiang Q, Wang F, Li Z*, Bian X*, Ye J*. Akt2 deficiency alleviates oxidative stress in the heart and liver via upregulating SIRT6 during high-fat diet-induced obesity. Clin Sci (Lond). 2023 May 15:CS20230433. Clin Sci (Lond). 2023 May 31;137(10):823-841. (IF=6.0). doi: 10.1042/CS20230433.
3) Shuya Gao#, Qingchen Yang#, Yue Peng, Weixian Kong, Zekun Liu, Zhe Li, Jiawen Chen, Mengmeng Bao, Xie Li, Yubin Zhang, Xiaohong Bian, Liang Jin, Hanwen Zhang, Yuexin Zhang, Daniel Sanchis*, Fangrong Yan*, Junmei Ye*. SIRT6 regulates obesity-induced oxidative stress via ENDOG/SOD2 signaling in the heart. Cell Biol Toxicol. . 2023 Aug;39(4):1489-1507.
doi: 10.1007/s10565-022-09735-z. (IF=6.819)
4) Shuya Gao#, Qingchen Yang#, Zekun Liu, Weixian Kong, Jiawen Chen, Xie Li, Yue Peng, Mengmeng Bao, Xiaohong Bian, Yuexin Zhang, Qizhou Jiang, Zhe Li, Yubin Zhang*, Fangrong Yan*, Junmei Ye*. Metformin alleviates HFD-induced oxidative stress in hepatocyte via activating SIRT6/PGC-1α/ENDOG signaling. Clin Sci (Lond). 2022, Nov 30;136(22):1711-1730. (IF=6.0)
doi: 10.1042/CS20220242.
5) Yue Peng, Qingchen Yang, Shuya Gao, Zekun Liu, Weixian Kong, Xiaohong Bian, Zhe Li*, Junmei Ye*. IL-6 protects cardiomyocytes from oxidative stress at the early stage of LPS-induced sepsis. Biochem Biophys Res Commun. 2022 May 7;603:144-152.
doi: 10.1016/j.bbrc.2022.03.013. (IF=3.575)
6) Mengxiao Wang, Bingbing Li, Fujian Qin, Junmei Ye*, Liang Jin*. Obesity induced Ext1 reduction mediates the occurrence of NAFLD. Biochem Biophys Res Commun. 2022 Jan 22;589:123-130.
doi: 10.1016/j.bbrc.2021.12.017. (IF=3.575)
7) Xiaofan Lu#, Caoyu Ji#, Liyun Jiang, Yue Zhu, Yujie Zhou, Jialin Meng, Jun Gao, Tao Lu*, Junmei Ye*, Fangrong Yan*. Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy. Cell Prolif . 2021 Mar;54(3):e12979.
doi: 10.1111/cpr.12979. (IF=8.755)
8) Miao Chen#, Caoyu Ji#, Qingchen Yang, Shuya Gao, Yue Peng, Zhe Li, Xingyu Gao, Yaoting Li, Nan Jiang, Yubin Zhang, Xiaohong Bian, Caiping Chen, Kaidi Zhang, Daniel Sanchis*, Fangrong Yan*, Junmei Ye*. AKT2 regulates development and metabolic homeostasis via AMPK-dependent pathway in skeletal muscle. Clin Sci (Lond). 2020 Sep 18;134(17):2381-2398.
doi: 10.1042/CS20191320.(IF=6.124)
9) Chen D#, Li Z#, Bao P, Chen M, Zhang M, Yan F, Xu Y, Ji C, Hu X, Sanchis D*, Zhang Y*, Ye J*. Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation. Biochim Biophys Acta Mol Basis Dis. 2019 Jun1; 1865(6):1253-1264.
doi: 10.1016/j.bbadis.2019.01.020.(IF=5.108)
10) Shuai Yang#, Dandan Chen#, Fan Chen, Xinmei Zhao, Yubin Zhang, Zhe Li, Liang Jin, Yitao Xu, Daniel Sanchis, Junmei Ye. Deletion of AKT2 preserves cardiac function by blocking IL-6-mediated injury and restores blood pressure during angiotensin II/high salt diet-induced hypertension. J Hypertension. 2018 Apr;36(4): 834-846. doi: 10.1097/HJH.0000000000001613.(IF=4.081)